RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS

被引：2
|
作者：
FitzGerald, O. [1 ,2 ]
Rubbert-Roth, A. [3 ]
Chen, K. [4 ]
Meerwein, S. [5 ]
Enejosa, J. [4 ]
Shaw, T. [4 ]
Wells, A. F. [6 ]
机构：
[1] Univ Coll Dublin, St Vincents Univ Hosp, Dublin, Ireland
[2] Univ Coll Dublin, Conway Inst, Dublin, Ireland
[3] Kantonsspital St Gallen, St Gallen, Switzerland
[4] AbbVie, N Chicago, IL USA
[5] AbbVie Deutschland, Ludwigshafen, Germany
[6] Rheum & Immunotherapy Ctr, Franklin, TN USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.4221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0239
引用
收藏
页码：981 / 981
页数：1
相关论文
共 50 条
  • [31] PREDICTORS OF AN INADEQUATE RESPONSE TO TREATMENT IN LATIN AMERICAN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Gamboa-Cardenas, R. V.
    Ugarte-Gil, M.
    Massardo, L.
    Sacnun, M. P.
    Granel, A.
    Catoggio, L.
    Lima-Correa, F. A.
    Appenzeller, S.
    Azevedo, A.
    Keiserman, M.
    Rueda, J.
    Zurita, L.
    Moreno, M.
    Cardiel, M.
    Acevedo-Vasquez, E.
    Alarcon, G. S.
    Pons-Estel, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1327 - 1327
  • [32] The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study
    Chang, Jie
    Wang, Gang
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [33] BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CSDMARDS
    van der Heijde, D.
    Dougados, M.
    Chen, Y. -C.
    Greenwald, M.
    Drescher, E.
    Klar, R.
    Xie, L.
    de la Torre, I.
    Rooney, T. P.
    Witt, S.
    Schlichting, D.
    DeBono, S.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 244 - 245
  • [34] IMPACT OF 12 WEEKS OF UPADACITINIB TREATMENT ON INDIVIDUAL AND COMPOSITE DISEASE MEASURES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC OR BIOLOGIC DMARDS
    van Vollenhoven, R.
    Dore, R.
    Chen, K.
    Camp, H. S.
    Enejosa, J.
    Shaw, T.
    Suboticki, J. L.
    Hall, S.
    RHEUMATOLOGY, 2019, 58 : 63 - 63
  • [35] Effectiveness of golimumab for rheumatoid arthritis in patients with an inadequate response to tocilizumab
    Matsuno, Hiroaki
    Katayama, Kou
    MODERN RHEUMATOLOGY, 2017, 27 (02) : 246 - 251
  • [36] IMPACT OF 12 WEEKS OF UPADACITINIB TREATMENT ON INDIVIDUAL AND COMPOSITE DISEASE MEASURES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC OR BIOLOGIC DMARDS
    van Vollenhoven, R.
    Dore, R.
    Chen, K.
    Camp, H. S.
    Enejosa, J.
    Shaw, T.
    Suboticki, J. L.
    Hall, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 984 - 984
  • [37] The changes of intestinal flora and its relevance with memory Tfh and B cells in rheumatoid arthritis patients treated with csDMARDs and csDMARDs plus bDMARDs
    Jiang, Chunlei
    Chi, Shuhong
    Wang, Fengkui
    Zhao, Chenyang
    Yang, Xiaojuan
    Liu, Miao
    Ma, Bin
    Chen, Jian
    Su, Chunxia
    Duan, Xiangguo
    IMMUNOBIOLOGY, 2024, 229 (03)
  • [38] Cost-effectiveness of treatment strategies for rheumatoid arthritis patients with inadequate response to methotrexate
    Patel, VD
    Hay, J
    VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
  • [39] Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment
    Emery, Paul
    RHEUMATOLOGY, 2012, 51 : V22 - V30
  • [40] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO BDMARDS: RESULTS FROM RA-BEYOND FOLLOWING 6.9 YEARS OF TREATMENT
    Caporali, R.
    Aletaha, D.
    Sanmarti, R.
    Takeuchi, T.
    Mo, D.
    Haladyj, E.
    Zaremba-Pechmann, L.
    Taylor, P. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 617 - 618
12345